top of page

The International School of Nanomedicine (Directors M. Masserini and M. Ferrari) has the pleasure to announce the training school and course entitled   “Challenges and Prospects of Nanomedicine for Brain Targeting” that will be held in Erice, Sicily, Italy, July 1-5  at the Ettore Majorana Foundation and Centre for Scientific Culture (ECMCSC).  

The aim of the event is to encourage and promote networking between young scientists in Nanomedicine and to provide an interdisciplinary forum for the exchange of ideas and discussion of new results in the field of these topics:

  • Blood-brain barrier models

  • Blood-brain barrier alterations in human brain disorders

  • New strategies to cross the blood-brain barrier

  • Smart nanotechnologies for therapy of neurodegenerative diseases and brain tumours

The course will be open to a maximum of 60 participants selected on the base of registration date. The course is open to Post-docs, PhD Students and in general to researchers of the field at any level of expertise. Each participant will have the opportunity to present his own research as poster or short oral presentation. 

Key Lecturers

  • Marzia Bedoni (Laboratory of Nanomedicine and Clinical Biophotonics (LABION), IRCCS Fondazione Don Carlo Gnocchi, Milan, Italy.

  • Gianni Ciofani (Italian Institute of Technology IIT, Pontedera, Italy) 

  • Marie Pierre Dehouck (University of Artois, Laboratoire de la Barrière Hémato Encéphalique (LBHE), Lens, France) 

  • Maria Anna Deli (Institute of Biophysics, Biological Research Centre, Szeged, Hungary)

  • Anna Dimberg (Department of Immunology, Genetics and Pathology, Science for Life Laboratory, The Rudbeck Laboratory, Uppsala University, Sweden) 

  • Francois Lux (Institut Lumière-Matière, Université de Lyon, France)

  • Charles Ramassamy (Institut National de la Recherche Scientifique, Armand-Frappier Institute, Laval, Québec, Canada)

  • Franziska Richter (Department of Pharmacology, Toxicology and Pharmacy, University of Veterinary Medicine Hannover,  Germany)

  • Bruno Sarmento (Institute for Research and Innovation in Health (i3S), University of Porto, Portugal)

  • Kamalindeer K. Singh (School of Pharmacy and Biomedical Sciences, University of Central Lancashire, Preston, UK) 

bottom of page